Metro Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 05-01-2025
- Paid Up Capital ₹ 0.50 M
as on 05-01-2025
- Company Age 24 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.42 Cr
as on 05-01-2025
- Satisfied Charges ₹ 2.60 M
as on 05-01-2025
- Revenue -12.39%
(FY 2022)
- Profit -25.08%
(FY 2022)
- Ebitda -128.94%
(FY 2022)
- Net Worth 4.16%
(FY 2022)
- Total Assets 0.80%
(FY 2022)
About Metro Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.42 Cr. The company has closed loans amounting to ₹2.60 M, as per Ministry of Corporate Affairs (MCA) records.
Rohit Mahajan, Neelam Gupta, and Seema Mahajan serve as directors at the Company.
- CIN/LLPIN
U24239DL2000PTC103605
- Company No.
103605
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Feb 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Metro Pharmaceuticals Private Limited offer?
Metro Pharmaceuticals Private Limited offers a wide range of products and services, including Gloves & Mittens, Cotton Gloves, Face Mask & Medical PPE Kits, Anti Pollution Mask, Industrial Uniforms & Safety Wear, Coated Gloves, Bed Linen & Bedspreads, Bed Sheets.
Who are the key members and board of directors at Metro Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Mahajan  | Whole-Time Director | 04-Feb-2000 | Current |
| Neelam Gupta | Director | 30-Oct-2009 | Current |
| Seema Mahajan | Director | 19-Dec-2018 | Current |
Financial Performance of Metro Pharmaceuticals.
Metro Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 12.39% decrease. The company also saw a substantial fall in profitability, with a 25.08% decrease in profit. The company's net worth moved up by a moderate rise of 4.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Metro Pharmaceuticals?
In 2020, Metro Pharmaceuticals had a promoter holding of 20.68% and a public holding of 79.32%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Mar 2022 | ₹1.40 M | Open |
Hdfc Bank Limited Creation Date: 27 Dec 2013 | ₹1.28 Cr | Open |
Canara Bank Creation Date: 26 Mar 2011 | ₹0.80 M | Satisfied |
How Many Employees Work at Metro Pharmaceuticals?
Unlock and access historical data on people associated with Metro Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Metro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Metro Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
